NTUH and AbbVie partner to advance digital strategies for clinical trials

Both parties will also expand research and development efforts.

National Taiwan University Hospital (NTUH) and AbbVie Biopharmaceuticals GmbH Taiwan Branch (AbbVie) have signed a cooperation agreement to strengthen digital strategies for clinical trials and promote prospective research.

Both organisations will expand research and development efforts, improve digital frameworks for clinical trials, and adopt innovative trial models.

The agreement was signed by NTUH President Ming-Shiang Wu and AbbVie General Manager Richard Sun.